findmyKOL

Matthew Zipse, MD

Basic profile

University of Colorado Anschutz Medical Campus

ORCIDNPI
RegionAurora, CO · WestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Matthew Zipse is a Cardiology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 187 publications with 1,690 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
187publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,690citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

12605 E 16th Ave
Aurora, CO 80045

Telephone

303-315-7424

Provider last certified this registry record 30 Dec 2025.

View the NPPES registry record

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    56.1%
    Beta blocker36%
    Metoprolol Succinate100%
    Part D21 patients
    Antiarrhythmic20.2%
    Flecainide Acetate100%
    Part D11 patients
  • Blood & clotting

    33.3%
    Factor Xa inhibitor33.3%
    Eliquis100%
    Part D15 patients
  • Anti-infectives

    10.5%
    Tetracycline-class Drug10.5%
    Doxycycline Hyclate100%
    Part D12 patients
Where care is delivered (Part B)97.1% facility · 2.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”